Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomized Double-blind Trial of VISUPRIME® Eye Drops to be Evaluated in Preventing the Conjunctival Bacterial Load in Patients Undergoing to Anti-VEGF Injection

NCT05677685 is registered in ClinicalTrials.gov with VISUfarma SpA as lead sponsor.

NCT NCT05677685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomized Double-blind Trial of VISUPRIME® Eye Drops to be Evaluated in Preventing the Conjunctival Bacterial Load in Patients Undergoing to Anti-VEGF Injection
Lead sponsor
VISUfarma SpA
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2023
Completion date
January 23, 2024
Enrollment
78 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, macular degeneration, age related, macular edema of right retina (diagnosis), myopic choroidal neovascularisation, proliferative diabetic retinopathy